News
-
-
COMMUNIQUÉ DE PRESSE
New to The Street Client NRx Pharmaceuticals (NASDAQ:NRXP) Secures FDA Fast Track Designation for NRX-100, Expanding Reach to 13 Million Americans Confronting Suicidal Ideation
NRx Pharmaceuticals receives FDA Fast Track Designation for NRX-100 in treating suicidal ideation in depression, expanding patient population and addressing unmet medical needs -
-
-
COMMUNIQUÉ DE PRESSE
New to The Street to Air Show #683 on Bloomberg, Featuring BioVie, FLOKI, PetVivo, and NRx Pharmaceuticals
New to The Street will air Show #683 on Bloomberg, featuring BioVie Inc., FLOKI, PetVivo Holdings, Inc., and NRx Pharmaceuticals, Inc. with insights on healthcare, biotech, blockchain gaming, and sports partnerships -
-
-
COMMUNIQUÉ DE PRESSE
New to The Street Launches 1,000+ Commercial TV Blitz for Synergy CHC ($SNYR), Makers of Focus Factor(R) - Adds NewsOut Video PR Coverage & NYC #1 Market Saturation
New to The Street launches massive TV commercial campaign for Synergy CHC Corp, featuring Focus Factor® on top networks and platforms -
-
